LEXX

Companies
NASDAQ
Lexaria Bioscience Corp.
Health Care
Price Chart
Overview

About LEXX

learn about working at legal adviser at sbde . co , legal adviser for mr mohamed kaaki, ceo for oversease business group. join linkedin today for free. see who you know at legal adviser at sbde . co , legal adviser for mr mohamed kaaki, ceo for oversease business group, leverage your professional network, and get hired.

Market Cap
$46.8M
Volume
84.0K
Avg. Volume
90.9K
P/E Ratio
-2.5128207
Dividend Yield
0.00%
Employees
3.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.00
Low Correlation
Volatility
Low (0.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for LEXX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, LEXX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$46.8M
Volume84.0K
P/E Ratio-2.51
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 14, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how LEXX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025